UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting



    YOQNEAM, ISRAEL & SAN RAMON, CALIF., October 11 /CNW/ - Results of an
independent multi-treatment clinical study of the UltraShape Contour I, the
first clinically proven non-invasive focused ultrasound solution for body
contouring, will be presented at the American Society for Dermatologic Surgery
annual meeting on October 11, 2007 in Chicago, Illinois. The presentation is
entitled "Non-invasive Ultrasonic Selective Destruction of Adipocytes using
UltraShape" and will take place during the scientific session Total Body
Rejuvenation.

    Hector Leal-Silva, M.D., a dermatologic surgeon based in Monterrey,
Mexico, will present the results of the 36 patient clinical study using the
UltraShape system on localized fat deposits in the abdomen, flanks, and
thighs. The study showed definitive, measurable results in 100 percent of
patients including an average of two-inch (5cm) reduction in circumference in
the abdomen after a series of three treatments, one month apart. Photographic
assessment, weight and circumferential measures were evaluated before and
after each treatment and one month after the last treatment. CT scans taken in
a subset of study subjects showed objectively quantifiable fat thickness
reduction. Ninety-four percent (94%) of patients were satisfied with the
procedure. In addition, there were no adverse events reported.

    "During my 18 month clinical experience, I continue to be impressed with
the UltraShape procedure," said Leal. "My clinical study demonstrated
measurable circumference reduction in all patients. These results were further
supported by CT scans in a subset of patients showing a sustained reduction in
fat thickness. In addition, the UltraShape procedure had high patient
satisfaction confirming that it is meeting patient expectations and the high
demand for safe and effective non-invasive fat reduction in today's aesthetic
practice."

    "Physicians and consumers are looking for an effective non-invasive fat
reduction and body contouring treatment that yields long-lasting results and
high patient satisfaction and have found this in UltraShape," said Rodger
Stewart, President and Chief Executive Officer of UltraShape Inc.

    About the UltraShape CONTOUR I

    The UltraShape Contour I system, based on patented focused ultrasound
technology, is the first scientifically and clinically proven non-invasive
body contouring solution for both men and women. The device produces
mechanical, non-thermal, acoustic effects which targets and selectively
destroys fat cells, leaving surrounding critical structures such as skin,
blood vessels, nerves, and connective tissue intact. The UltraShape procedure
is guided by proprietary real-time tracking and guidance technology designed
to deliver smooth, uniform body contouring results. The software guarantees
adherence to a pre-determined treatment algorithm minimizing risk of contour
irregularities, a common side effect of liposuction. The UltraShape procedure
is performed during a convenient, "walk-in, walk-out" session carried out in
an office-based environment; it requires no anesthesia or sedation, and the
vast majority of patients report no pain or discomfort. After treatment,
patients immediately resume their daily routines with no need for maintenance
treatments. The UltraShape procedure is available in 47 countries and over
40,000 patient treatments have been performed worldwide with high patient
satisfaction. The UltraShape Contour I received the CE Mark in 2005 and a
medical device license from Health Canada in 2007. The UltraShape Contour I
system is not available for sale in the United States.

    About UltraShape

    UltraShape is redefining aesthetic medicine by developing, manufacturing
and marketing innovative non-invasive technologies for body contouring. The
company is dedicated to providing clinically proven safe and effective
solutions that enhance the lives of patients worldwide. The UltraShape
proprietary non-invasive body contouring technology is based on focused
ultrasound that targets and selectively disrupts fat cells without affecting
surrounding structures. Founded in 2000, UltraShape is a privately held and
venture backed company with offices in the United States, Israel, France,
United Kingdom, and Italy. For more information visit www.ultrashape.com.




For further information:

For further information: UltraShape Abigail Marks +972-4-909-9260
abigail@ultrashape.com or FischerHealth Paula Moggio 310-577-7870 x151
pmoggio@fischerhealth.com or Gitam Porter Novelli Jessica Fishman
+972-3-576-5798 jessica@gitam.co.il

Organization Profile

ULTRASHAPE

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890